Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,62116,640 of 20,252 grants

Active NON-SBIR/STTR RPGS
Impact of Host NF-kB Signaling in Radiation Therapy
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

PROJECT SUMMARY / ABSTRACT Investigation of cytoplasmic-to-nuclear (C→N) NF-κB signaling pathways induced by various cell surface receptors has significantly expanded the knowledge...

$3.69M
USD
Active NON-SBIR/STTR RPGS
Novel DNA damage response therapeutics targeting replication protein A
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

Novel DNA damage response therapeutics targeting replication protein A Abstract The DNA damage response (DDR) is now considered a tractable pathway to target for cancer therapy. Th...

$4.97M
USD
Completed NON-SBIR/STTR RPGS
Structural Surfaceomics: A Strategy for Immunotherapy Target Discovery
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Engineered cellular therapies, such as CAR-T cells, hold great promise as “living drugs”. However, the application of this approach beyond B-cell origin ma...

$2.21M
USD
Active NON-SBIR/STTR RPGS
THE ROLE OF SELENOPROTEIN SYNTHESIS PATHWAY IN ACUTE MYELOID LEUKEMIA
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

AML is the most common acute leukemia in adults, and it appears increasingly with age. Despite overall improvement in the treatment of leukemia, AML still carries a devastating pro...

$4.56M
USD
Completed NON-SBIR/STTR RPGS
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2025

PROJECT SUMMARY Osteosarcoma (OS) is the most common malignant bone tumor, found in the pediatric population and often leads to death due to tumor progression and metastasis. Despi...

$4.08M
USD
Completed NON-SBIR/STTR RPGS
Therapeutic potential of targeting DNA repair deficiency in TSC
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2024

PROJECT SUMMARY/ ABSTRACT Using next-generation sequencing, researchers have identified somatic mutations as essential for tumor etiology and evolution. We now know that many cance...

$1.79M
USD
Completed NON-SBIR/STTR RPGS
Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2024

PROJECT SUMMARY Clinical implementation of Precision Medicine faces major challenges in precision disease stratification and staging, determining optimal treatment, monitoring ther...

$3.35M
USD
Active NON-SBIR/STTR RPGS
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY The epidermal growth factor (EGFR) oncogene is amplified and drives tumor growth in 55% of adult glioblastomas (GBMs). However, EGFR inhibitors have failed to demon...

$6.72M
USD
Completed NON-SBIR/STTR RPGS
Oligomannose antigens as conserved immunological targets of Non-Hodgkin lymphomas
NATIONAL CANCER INSTITUTE Sri International United States 2021 – 2025

PROJECT SUMMARY Non-Hodgkin lymphoma (NHL) is primarily of B-cell origin but is substantially heterogeneous, which makes developing a tumor-specific immunotherapy for it difficult....

$3.05M
USD
Active NON-SBIR/STTR RPGS
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2026

Abstract In recent years, the incidence of colorectal cancer (CRC) under the age of 50-years has increased significantly and population-based screening is currently not offered to...

$6.71M
USD
Active NON-SBIR/STTR RPGS
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

ABSTRACT With recent enactment of the Research to Accelerate Cures and Equity (RACE) for Children Act, there is a growing impetus to identify pediatric indications for molecularly...

$7.15M
USD
Completed NON-SBIR/STTR RPGS
Adapting and implementing evidence-based breast cancer follow-up in primary care
NATIONAL CANCER INSTITUTE Rbhs-Robert Wood Johnson Medical School United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Breast cancer survivors are a growing population and their symptom burden is significant. Despite growing evidence on specific symptoms and risk management...

$6.38M
USD
Active NON-SBIR/STTR RPGS
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

Abstract Philadelphia-positive acute lymhoblastic leukemia (Ph+ ALL) and Ph1-like B-ALL account for most cases of “high-risk” adult B-ALL. Current therapies with tyrosine kinase in...

$6.19M
USD
Completed NON-SBIR/STTR RPGS
Increasing aerobic and muscle-strengthening physical activity in Latinas via interactive web-based technology
NATIONAL CANCER INSTITUTE Brown University United States 2021 – 2024

ABSTRACT Cancer is the leading cause of death among Latinos in the U.S. While engaging in a physically active lifestyle is one of the most important modifiable behaviors for reduci...

$797.5K
USD
Active NON-SBIR/STTR RPGS
Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

SUMMARY Background. Triple-negative breast cancers (TNBCs) present with advanced histological grade and aggressive clinical behavior. They are overwhelmingly unresponsive to conven...

$4.41M
USD
Active NON-SBIR/STTR RPGS
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Project Summary Resistance to therapy is the major challenge for the treatment of pancreatic cancer. Despite recent successes in immune checkpoint therapy of several human cancer t...

$4.63M
USD
Active NON-SBIR/STTR RPGS
Germline and Somatic Genomic Studies in CLL Minorities
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

African Americans are significantly underrepresented in cancer research. Although there have been recent efforts toward more inclusion of African Americans in cancer research, subs...

$6.49M
USD
Active NON-SBIR/STTR RPGS
Hexokinase 2 and cancer therapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2026

Cancer cells are metabolically different from normal matching cells, and this is manifested by the high rate of glucose metabolism in cancer cells. The high rate of glucose metabol...

$5.63M
USD
Completed NON-SBIR/STTR RPGS
Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE Versiti Wisconsin, Inc United States 2021 – 2025

Supported by R01CA254354: Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia (AML) we have reported that the lysine deacylase SIRT5 is a druggable metabolic target i...

$3.71M
USD
Completed TRAINING, INDIVIDUAL
Elucidating the molecular mechanisms of PRMT5i response and resistance in LUAD and PDAC
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2021 – 2024

Project Summary Protein arginine methyltransferase 5 (PRMT5) is part of a methyltransferase complex that symmetrically dimethylates arginine residues in a wide range of proteins re...

$698K
USD